PMCB (PharmaCyte Biotech, Inc. Common Stock)
Iron Condor Setups
Iron condor opportunities for PMCB based on the same scoring engine used in the Iron Condor Screener: breach rate, average straddle, IV rank, IV premium, and beta-adjusted scoring. Updated every 5 minutes during market hours.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
PMCB doesn't currently meet the default iron-condor screening criteria
(breach rate ≤ 40%, avg straddle ≥ $10). Try the
full Iron Condor Screener with
relaxed filters, or check PMCB's
expected-move history
to understand its volatility regime.
PMCB IV Rank — Last 30 Days
| Date | IV Rank |
|---|---|
| 20260925 | 46% |
| 20260924 | 63% |
| 20260923 | 45% |
| 20260922 | 42% |
| 20260921 | 70% |
| 20260918 | 58% |
| 20260917 | 39% |
| 20260916 | 55% |
| 20260915 | 91% |
| 20260914 | 92% |
| 20260911 | 40% |
| 20260910 | 25% |
| 20260909 | 16% |
| 20260908 | 71% |
| 20260904 | 68% |
| 20260903 | 67% |
| 20260902 | 100% |
| 20260901 | 100% |
| 20260831 | 49% |
| 20260828 | 56% |
| 20260827 | 53% |
| 20260826 | 51% |
| 20260825 | 50% |
| 20260824 | 47% |
| 20260821 | 46% |
| 20260820 | 38% |
| 20260819 | 60% |
| 20260818 | 46% |
| 20260817 | 76% |
| 20260814 | 39% |